MedTrace Logo

Percutaneous Versus EUS FNAC in Pancreatic Masses

NCT04623749 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-06-14

No results posted yet for this study

Summary

We aim to evaluate the role of Ultrasound-guided (USG) fine needle aspiration cytology (FNAC) in diagnosis of pancreatic masses compared to endoscopic ultrasound (EUS) guided fine needle aspiration cytology (FNAC).

Conditions

  • Pancreatic Neoplasm
  • Pancreatic Cyst
  • Pancreatic Abscess

Interventions

PROCEDURE

US

Percutaneous Ultrasound guided FNAC

PROCEDURE

EUS

Endoscopic Ultrasound guided FNAC

Sponsors & Collaborators

  • Ola Kamal Mohammed Galal

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2022-12-31
Completion
2023-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04623749 on ClinicalTrials.gov